Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Celgenekey operating metrics including Phase III Trials Products (Inflammation and Immunology).

Phase III Trials Products (Inflammation and Immunology)

4
100.0%

FY, 2018

Filed Trials Products (Solid Tumors)

4

FY, 2018

Phase I Trials Products (Cellular Therapies)

2

FY, 2016

Operating Metrics

MetricsFY, 2016FY, 2017FY, 2018
Phase III Trials Products (Inflammation and Immunology)524
Filed Trials Products (Solid Tumors)444
Phase I Trials Products (Cellular Therapies)2
Phase II Trials Products (Cellular Therapies)2
Filed Trials Products (Lymphoma)466
Phase I Trials Products (Lymphoma)555
Phase III Trials Products (Lymphoma)433
Filed Trials Products (Acute Myeloid Leukemia)233
Phase I Trials Products (Acute Myeloid Leukemia)323
Phase III Trials Products (Acute Myeloid Leukemia)111
Phase II Trials Products (Solid Tumors)33
Phase I Trials Products (Solid Tumors)453
Phase III Trials Products (Solid Tumors)114
Phase III Trials Products (Beta Thalassemia)111
Filed Trials Products (Myelodysplastic Syndromes)222
Phase I Trials Products (Myelodysplastic Syndromes)11
Phase II Trials Products (Myelodysplastic Syndromes)221
Phase III Trials Products (Myelodysplastic Syndromes)222
Filed Trials Products (Multiple Myeloma)455
Phase I Trials Products (Multiple Myeloma)644
Phase I Trials Products (Chronic Lymphocytic Leukemia)21
Active Clinical Studies52
Phase II Trials Products (Acute Myeloid Leukemia)11
Filed Trials Products (Inflammation and Immunology)222
Phase I Trials Products (Inflammation and Immunology)333
Phase II Trials Products (Inflammation and Immunology)663
Phase II Trials Products (Multiple Myeloma)11
Phase I/II Trials Products (Lymphoma)11
Phase I/II Trials Products (Chronic Lymphocytic Leukemia)11
Phase II Trials Products (Myelofibrosis)11
Phase I/II Trials Products (Multiple Myeloma)1

Footer menu